[HTML][HTML] Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February

…, D Evans, SJW Evans, AJ Walker, G Hickman… - …, 2021 - eurosurveillance.org
The SARS-CoV-2 B.1.1.7 variant of concern (VOC) is increasing in prevalence across Europe.
Accurate estimation of disease severity associated with this VOC is critical for pandemic …

[HTML][HTML] Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in …

…, R Croker, S Bacon, G Hickman… - The Lancet …, 2022 - thelancet.com
Background The risk of severe COVID-19 outcomes in people with immune-mediated
inflammatory diseases and on immune-modifying drugs might not be fully mediated by …

Severity of severe acute respiratory system coronavirus 2 (SARS-CoV-2) alpha variant (B. 1.1. 7) in England

…, D Evans, AJ Walker, G Hickman… - Clinical Infectious …, 2022 - academic.oup.com
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) alpha
variant (B.1.1.7) is associated with higher transmissibility than wild-type virus, becoming the …

[HTML][HTML] Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the …

…, CE Morton, SCJ Bacon, G Hickman… - The Lancet public …, 2023 - thelancet.com
Background COVID-19 has been shown to differently affect various demographic and
clinical population subgroups. We aimed to describe trends in absolute and relative COVID-19-…

[HTML][HTML] Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and …

K Bhaskaran, CT Rentsch, G Hickman, WJ Hulme… - PLoS …, 2022 - journals.plos.org
Background There is concern about medium to long-term adverse outcomes following acute
Coronavirus Disease 2019 (COVID-19), but little relevant evidence exists. We aimed to …

Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY

…, J Morley, A Mehrkar, S Bacon, G Hickman… - British Journal of …, 2021 - bjgp.org
Background Long COVID describes new or persistent symptoms at least 4 weeks after onset
of acute COVID-19. Clinical codes to describe this phenomenon were recently created. Aim …

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the …

…, S Davy, J Cockburn, CE Morton, G Hickman… - bmj, 2022 - bmj.com
Objective To compare the effectiveness of sotrovimab (a neutralising monoclonal antibody)
with molnupiravir (an antiviral) in preventing severe outcomes of covid-19 in adult patients …

Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY

…, J Morley, A Mehrkar, S Bacon, G Hickman… - British Journal of …, 2022 - bjgp.org
Background On 8 December 2020 NHS England administered the first COVID-19
vaccination. Aim To describe trends and variation in vaccine coverage in different clinical and …

Carbon exchange by establishing biofuel crops in Central Illinois

M Zeri, K Anderson-Teixeira, G Hickman… - Agriculture, ecosystems …, 2011 - Elsevier
Perennial grass biofuels may contribute to long-term carbon sequestration in soils, thereby
providing a broad range of environmental benefits. To quantify those benefits, the carbon …

A comparison of canopy evapotranspiration for maize and two perennial grasses identified as potential bioenergy crops

GC Hickman, A Vanloocke, FG Dohleman… - Gcb …, 2010 - Wiley Online Library
In the Midwestern US, perennial rhizomatous grasses (PRGs) are considered one of the
most promising vegetation types to be used as a cellulosic feedstock for renewable energy …